Man Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.7M | Sell |
|
|||||
|
2025
Q1 | $16.5M | Buy |
|
|||||
|
2024
Q4 | $12.5M | Sell |
|
|||||
|
2024
Q3 | $18.2M | Sell |
|
|||||
|
2024
Q2 | $25.8M | Buy |
|
|||||
|
2024
Q1 | $7.17M | Buy |
|
|||||
|
2023
Q4 | $4.2M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.95M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.77M | Buy |
|
|||||
|
2022
Q3 | $1.43M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $488K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.9M | Sell |
|
|||||
|
2020
Q4 | $6.25M | Buy |
|
|||||
|
2020
Q3 | $2.68M | Buy |
|
|||||
|
2020
Q2 | $2.23M | Sell |
|
|||||
|
2020
Q1 | $1.66M | Sell |
|
|||||
|
2019
Q4 | $4.11M | Buy |
|
|||||
|
2019
Q3 | $2.2M | Sell |
|
|||||
|
2019
Q2 | $4.29M | Sell |
|
|||||
|
2019
Q1 | $5.39M | Buy |
|
|||||
|
2018
Q4 | $1.87M | Sell |
|
|||||
|
2018
Q3 | $3.77M | Buy |
|